John D. Diekman, 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 524,306 shares at $21.88 ($11.5M) on 2019-01-22, disclosed to the SEC on 2019-01-24.
Open-market sale of $11.5M CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.88 | 10,486 | $229K | 2.0% |
| 2 | $21.88 | 10,486 | $229K | 2.0% |
| 3 | $21.88 | 251,667 | $5.5M | 48.0% |
| 4 | $21.88 | 251,667 | $5.5M | 48.0% |
| Total | $21.88 avg | 524,306 | $11.5M | 100% |
| Filing → |
| ZLAB | SELL | 2022-02-07 | $50K | — | Filing → |
| ZLAB | SELL | 2021-11-08 | $92K | — | Filing → |
| ZLAB | SELL | 2021-08-05 | $150K | — | Filing → |